Financial Performance - The company's revenue for Q1 2023 reached ¥507,036,038.28, representing a 55.72% increase compared to ¥325,602,548.36 in the same period last year[5] - Net profit attributable to shareholders was ¥34,367,138.27, a significant increase of 300.26% from ¥8,586,259.32 year-on-year[5] - Basic earnings per share rose to ¥0.09, up 350.00% from ¥0.02 in the same quarter last year[5] - Net profit for Q1 2023 reached CNY 34,757,287.53, compared to CNY 7,840,202.57 in Q1 2022, marking a 343.5% year-over-year growth[22] - Earnings per share for Q1 2023 were CNY 0.09, up from CNY 0.02 in the previous year[22] Cash Flow - The net cash flow from operating activities improved to ¥16,299,395.61, a turnaround from a negative cash flow of ¥211,055,777.87 in the previous year, marking a 107.72% increase[11] - Total cash inflow from operating activities reached ¥756,540,254.35, up from ¥507,935,656.39 in the same period last year, indicating a growth of approximately 48.9%[25] - Cash outflow from operating activities was ¥740,240,858.74, slightly higher than ¥718,991,434.26 in Q1 2022, reflecting a 2.5% increase[25] - The net cash flow from financing activities was ¥138,835,467.42, a decrease from ¥512,264,098.95 in the same quarter last year[26] - The ending balance of cash and cash equivalents was ¥473,903,542.81, compared to ¥542,503,720.50 at the end of Q1 2022, indicating a decline of about 12.6%[26] Assets and Liabilities - Total assets increased by 4.48% to ¥6,417,213,846.78 from ¥6,141,884,381.15 at the end of the previous year[5] - The total liabilities as of Q1 2023 were CNY 4,015,144,427.65, an increase from CNY 3,774,572,249.55 in the previous year[21] - The total equity attributable to shareholders of the parent company was CNY 2,399,285,244.79, up from CNY 2,364,918,106.52[21] Research and Development - The company reported a 58.88% increase in R&D expenses, totaling ¥30,282,381.38, reflecting a commitment to innovation[10] - Research and development expenses increased to CNY 30,282,381.38, compared to CNY 19,060,043.19 in the same quarter last year, indicating a focus on innovation[21] Shareholder Information - The company has a share repurchase account holding 6,854,198 shares as of the reporting period[13] - The company’s major shareholders include Kairun Holdings Investment Co., Ltd. with 116,251,200 shares, representing a significant portion of the total shares[13] Strategic Initiatives - The company’s management indicated plans for future market expansion and potential new product development, although specific figures were not disclosed during the call[13] - The company is focusing on market expansion and product development as part of its strategic initiatives for future growth[20] Government Support - The company received government subsidies amounting to ¥33,803,001.08, a 415.38% increase compared to the previous year[10] Financial Expenses - The company reported a significant decrease in financial expenses, with a net financial cost of CNY 11,517,361.21 compared to a gain of CNY 1,881,184.03 in the previous year[21] Inventory and Receivables - Inventory levels rose significantly to CNY 226,313,226.14, compared to CNY 142,881,970.88 at the beginning of the year, marking an increase of around 58.3%[18] - Accounts receivable increased to CNY 1,756,406,749.11 from CNY 1,697,500,887.91, representing a rise of approximately 3.5%[18] - The company reported a decrease in notes receivable from CNY 252,591,328.49 to CNY 121,945,304.49, a decline of approximately 51.6%[18] Audit Information - The company did not conduct an audit for the Q1 report[27]
凯伦股份(300715) - 2023 Q1 - 季度财报